Medicine and Dentistry
Neurofibromatosis Type I
100%
Central Venous Catheter
60%
Catheter Infection
41%
Cohort Analysis
41%
Disease
34%
Bloodstream Infection
31%
Plexiform Neurofibroma
26%
Pediatrics Patient
25%
Blood Culture
25%
Infection
22%
Disease Severity
21%
Tuberous Sclerosis
20%
Acute Lymphoblastic Leukemia
20%
Mosaicism
20%
Brain Tumor
20%
Clinical Feature
20%
Lysosomal Storage Disease
20%
Superficial Vein
20%
Noonan Syndrome
20%
Hypertrophic Cardiomyopathy
20%
Atypical Teratoid Rhabdoid Tumor
20%
Taurolidine
20%
Silicone Gel
20%
Odds Ratio
20%
Endocrine Disease
15%
Antibiotic Therapy
15%
Neoplasm
13%
Batten Disease
10%
Antibiotics
10%
Signal Transduction
10%
Erythema Chronicum Migrans
10%
Ataxia
10%
Neuroborreliosis
10%
MAPK Signaling
10%
Pulmonary Valve Stenosis
10%
Childbirth
9%
Combination Therapy
8%
Fusidic Acid
8%
Catheter Removal
7%
Ventricle of Heart
6%
Catheter Complication
6%
Rare Tumor
6%
Drug Therapy
6%
Pediatrics
6%
Rare Disease
5%
MEK Inhibitor
5%
Meropenem
5%
Ceroid
5%
Sinus Arrest
5%
Carcinogen
5%
Pharmacology, Toxicology and Pharmaceutical Science
Hypertrophic Cardiomyopathy
40%
Tuberous Sclerosis
20%
Catheter Infection
20%
Taurolidine
20%
Silicone Gel
20%
Cytarabine
20%
Bacteremia
20%
Noonan Syndrome
20%
Chemotherapy
10%
Pulmonary Valve Stenosis
10%
Infection
10%
Combination Therapy
8%
Malignant Neoplasm
8%
Disease
8%
Penicillin Derivative
6%
Congestive Heart Failure
6%
Side Effect
6%
Heart Death
6%
Mitogen Activated Protein Kinase
6%
Mitogen Activated Protein Kinase Kinase
6%
Heart Ventricle Hypertrophy
5%
Carcinogen
5%
Mitogen Activated Protein Kinase Kinase Inhibitor
5%
Trametinib
5%
Remission
5%
